US › Healthcare

PharmaCyte Biotech Inc (PMCB)

US · Healthcare · Biotechnology

$0.60+4.38%
Last close · 2026-08-04

Latest quarter · ended 2026-04-30

Net profit
$-4.4M
Profit YoY
-137.4%
EPS
$-0.01

Key statistics

Market cap
$6.2M
Forward P/E
7.0
P/B
0.16
Book value
$3.59
EPS (TTM)
$-0.89
52-week high
$1.51
52-week low
$0.55
50-day MA
$0.71
200-day MA
$0.78
Beta
0.68

Shareholding

Insiders
5.74%
Institutions
9.11%

Largest institutional holders

FundStake
Citadel Advisors Llc3.35%
Geode Capital Management, LLC1.82%
Renaissance Technologies Corp0.53%
XTX Topco Ltd0.49%
Vanguard Capital Management, LLC0.48%
Virtu Financial LLC0.35%
Northern Trust Corp0.33%
Schonfeld Strategic Advisors LLC0.25%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for PharmaCyte Biotech Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.